Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer’s disease

Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease

(2022) Yuqing Liu et al.   Frontiers in Immunology

SIRT1, MMP-9 and TIMP-1 levels in children with specific learning disorder

(2022) Cansu Mercan Isik et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease

(2021) Elisabeth H. Thijssen et al.   Scientific Reports

Biomarkers for neurodegenerative diseases

(2021) Oskar Hansson   NATURE MEDICINE

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

(2021) Charlotte E Teunissen et al.   LANCET NEUROLOGY

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

(2020) Longfei Jia et al.   Lancet Public Health

Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Maigeng Zhou et al.   LANCET

Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier

(2019) Ben Shackleton et al.   MOLECULAR NEUROBIOLOGY

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease

(2019) Christopher D. Whelan et al.   Acta Neuropathologica Communications

Mortality of Alzheimer’s Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai

(2019) Yue-Qi Zhang et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

The cost of Alzheimer's disease in China and re-estimation of costs worldwide

(2018) Jianping Jia et al.   Alzheimers & Dementia

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease

(2018) Maria Bjerke et al.   JOURNAL OF ALZHEIMERS DISEASE

Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease

(2018) Nastasia K.-H. Lim et al.   JOURNAL OF ALZHEIMERS DISEASE

Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid

(2018) Cecilia E. Hanzel et al.   JOURNAL OF ALZHEIMERS DISEASE

Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

(2018) Barbara Mroczko et al.   JOURNAL OF ALZHEIMERS DISEASE

Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia

(2018) Gamze Tuna et al.   JOURNAL OF ALZHEIMERS DISEASE

Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

(2016) Subodh Kumar et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

(2016) Ralf G Rempe et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease

(2015) Matthew R Halliday et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases

(2015) Marjana Brkic et al.   MEDIATORS OF INFLAMMATION

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

(2012) Robert D. Bell et al.   NATURE

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

(2010) Solveig Horstmann et al.   INTERNATIONAL PSYCHOGERIATRICS

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

(2010) Erik Stomrud et al.   Alzheimers Research & Therapy

Matrix Metalloprotease-9 Inhibition Improves Amyloid  -Mediated Cognitive Impairment and Neurotoxicity in Mice

(2009) H. Mizoguchi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS